FindTrial
Sign In

a study on atopic dermatitis

A CLINICAL STUDY TO ASSESS THE EFFECTIVENESS OF INDIVIDUALIZED HOMOEOPATHIC MEDICINES IN THE MANAGEMENT OF ATOPIC DERMATITIS

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/05/052816
Enrollment
30
Registered
2023-05-18
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L209- Atopic dermatitis, unspecified

Interventions

Intervention1: administration of individualized homoeopathic medicine: Following obtaining consent and screening using specified selection (inclusion and exclusion) criteria, 30 eligible patients will

Sponsors

NEHRU HOMEOEOPATHIC MEDICAL COLLEGE AND HOSPITAL
Lead Sponsor
nehru homoeopathic medical college
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1.Subjects who satisfy the Hanifin and Rajkaâ??s criteria for atopic dermatitis 2.Subjects of both sexes of age group 5-70 yrs

Exclusion criteria

Exclusion criteria: 1.Patients who are taking other modes of treatment 2.Patients who are too sick for consultation, unable to read patient information sheet, unwilling to take part or not giving consent to join the study. 3.Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or life-threatening illness affecting quality of life or any organ failure. 4.Pregnant women and lactating mothers. 5.Substance abuse and/or dependence.

Design outcomes

Primary

MeasureTime frame
SCORAD index Timepoint: ONCE EVERY WEEK FOR A MONTH AND THEN AFTER EVERY 15 DAYS—

Secondary

MeasureTime frame
DLQITimepoint: ONCE EVERY WEEK FOR A MONTH AND THEN AFTER EVERY 15 DAYS—

Countries

India

Contacts

Public ContactVEENA T

NHMC DELHI

rakeshthakkar14@gmail.com8851006347

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026